Amy Holroyd

1.7k total citations
5 papers, 54 citations indexed

About

Amy Holroyd is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, Amy Holroyd has authored 5 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Surgery. Recurrent topics in Amy Holroyd's work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers). Amy Holroyd is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers). Amy Holroyd collaborates with scholars based in United Kingdom, United States and Sweden. Amy Holroyd's co-authors include Richard S. Houlston, Mark T. Drayson, Martin Kaiser, Roger G. Owen, Kevin Litchfield, Douglas F. Easton, Graham Jackson, Clare Turnbull, Matthew Jenner and Rosalind A. Eeles and has published in prestigious journals such as Nature Communications, Blood and Oncotarget.

In The Last Decade

Amy Holroyd

4 papers receiving 53 citations

Peers

Countries citing papers authored by Amy Holroyd

Since Specialization

Citations

This map shows the geographic impact of Amy Holroyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Holroyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Holroyd more than expected).

Fields of papers citing papers by Amy Holroyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Holroyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Holroyd. The network helps show where Amy Holroyd may publish in the future.

Co-authorship network of co-authors of Amy Holroyd

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Holroyd. A scholar is included among the top collaborators of Amy Holroyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Holroyd. Amy Holroyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Extended Intensified Consolidation and Maintenance Improve Ultra High-Risk Multiple Myeloma Patient Outcome - Long-Term Follow-up of the Ukmra Optimum/Muknine Trial 2024 ·Blood ·Martin Kaiser, Andrew Hall, (unknown), Amy Holroyd, Eugene B. Ferris, (unknown), (unknown), Kristian M. Bowles, Mamta Garg, Anand Lokare, Ruth M. de Tute, Mark T. Drayson, Christina Messiou, Roger G. Owen, Richard S. Houlston, Graham Jackson, Gordon Cook, Guy Pratt, Sarah Brown, Matthew Jenner	0
2	Ultra High-Risk Multiple Myeloma Patients with Multi-Hit Tumours and SKY92 High Risk Signature Are at Increased Risk of Early Relapse Even When Treated with Extended Intensified Induction and Consolidation - Results from the Optimum/Muknine Trial 2023 ·Blood ·Martin Kaiser, (unknown), Andrew Hall, Amy Holroyd, (unknown), Ruth M. de Tute, (unknown), (unknown), Graham Jackson, Gordon Cook, Richard S. Houlston, Mark T. Drayson, Roger G. Owen, Guy Pratt, Sarah Brown, Matthew Jenner	5
3	Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial 2022 ·Blood ·(unknown), David A. Cairns, Amy Holroyd, (unknown), (unknown), Charlotte Pawlyn, Gordon Cook, Mark T. Drayson, Kevin Boyd, Faith E. Davies, Matthew Jenner, Gareth J. Morgan, Roger G. Owen, Richard S. Houlston, Graham Jackson, Martin Kaiser	21
4	Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer 2017 ·Oncotarget ·Chey Loveday, Kevin Litchfield, Max Levy, Amy Holroyd, Peter Broderick, Zsofia Kote‐Jarai, Alison M. Dunning, Kenneth Muir, Julian Peto, Rosalind A. Eeles, Douglas F. Easton, Darshna Dudakia, Nick Orr, Nora Pashayan, Alison Reid, Robert Huddart, Richard S. Houlston, Clare Turnbull	6
5	Identification of four new susceptibility loci for testicular germ cell tumour 2015 ·Nature Communications ·Kevin Litchfield, Amy Holroyd, Amy Lloyd, Peter Broderick, Jérémie Nsengimana, Rosalind A. Eeles, Douglas F. Easton, Darshna Dudakia, D. Timothy Bishop, Alison Reid, Robert Huddart, Tom Grotmol, Fredrik Wiklund, Janet Shipley, Richard S. Houlston, Clare Turnbull	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact